LADENBURG THALMANN FINANCIAL SERVICES INC. - OCULAR THERAPEUTIX INC ownership

OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 76 filers reported holding OCULAR THERAPEUTIX INC in Q1 2017. The put-call ratio across all filers is 0.60 and the average weighting 0.5%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of OCULAR THERAPEUTIX INC
ValueSharesWeighting
Q2 2018$7,0000.0%1,1000.0%0.00%
Q1 2018$7,000
+40.0%
1,1000.0%0.00%
Q4 2017$5,000
+400.0%
1,100
+1000.0%
0.00%
Q3 2017$1,0000.0%1000.0%0.00%
Q2 2017$1,000
-80.0%
100
-80.0%
0.00%
Q1 2017$5,0005000.00%
Other shareholders
OCULAR THERAPEUTIX INC shareholders Q1 2017
NameSharesValueWeighting ↓
SUMMER ROAD LLC 3,784,850$15,064,00062.56%
Versant Venture Management, LLC 2,215,384$8,817,228,0004.36%
SV Health Investors, LLC 628,236$2,500,0001.54%
DELTEC ASSET MANAGEMENT LLC 724,747$2,885,0000.80%
Endurant Capital Management LP 232,727$926,0000.49%
NOTTINGHAM ADVISORS, INC. 146,946$1,011,0000.15%
JGP Global Gestao de Recursos Ltda. 12,568$50,0000.06%
Man Group plc 1,187,508$4,726,0000.02%
Dynamic Technology Lab Private Ltd 21,077$84,0000.02%
NewEdge Advisors, LLC 36,250$144,0000.01%
View complete list of OCULAR THERAPEUTIX INC shareholders